Physician profile
Noah C Federman
NPI 1306045398
$399,472.21
in general payments reported to CMS, 2019-2025
11 companies · $68K in 2025
The $68K reported for 2025 was more than what 97% of Pediatric Hematology-Oncology providers received nationally (typical 2025 total: $207).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80K · 2020: $21K · 2021: $19K · 2022: $40K · 2023: $50K · 2024: $122K · 2025: $68K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $132K · Consulting Fee: $78K · Travel and Lodging: $22K · Food and Beverage: $8,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $131,950.00 |
| Consulting Fee | $78,135.35 |
| Travel and Lodging | $21,843.39 |
| Food and Beverage | $8,008.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $208,279.36 | 2019-2025 | |
| Springworks Therapeutics, INC. | $139,749.35 | 2024-2025 | Ogsiveo |
| Fennec Pharmaceuticals, INC. | $45,105.52 | 2023-2024 | Pedmark |
| Lantheus Medical Imaging, INC. | $6,220.89 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $74.83 | 2024 | |
| Zimmer Biomet Holdings, INC. | $42.26 | 2019 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noah Federman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.